ClinicalTrials.Veeva

Menu

Cross-Over Evaluation of Two Lubricating Eye Drops

I

Innovative Medical

Status and phase

Completed
Phase 4

Conditions

Dry Eye

Treatments

Drug: Polyethylene Glycol 400 0.4%
Drug: Propylene Glycol 0.3%
Drug: sodium chloride
Drug: sodium phosphate monobasic
Drug: 0.15% sodium Hyaluronate

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

To evaluate the efficacy of two lubricating eye drops for the treatment of dry eye signs and symptoms.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients 18 yrs or older
  2. Males or females
  3. Any race or ethnic background
  4. Patients with present ocular surface discomfort and a SESoD score of at least 2

Exclusion criteria

  1. Corneal refractive surgery within 6 months of this study.
  2. Contact lens use on day of examination.
  3. Corneal ectasia.
  4. Current use of Restasis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems